A Phase II Study of Adding the Multikinase Inhibitor Sorafenib (NEXAVAR) to Existing Endocrine Therapy in Patients with Advanced Breast Cancer

  • Massarweh, Suleiman (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date9/18/07 → 3/31/10